Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3
Dimerix Limited (ASX:DXB) has confirmed it's begun recruiting adolescent kidney disease patients in Mexico, now that its first Phase 3 clinical trial location has been selected.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online